Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung.

Authors Kelly J. Butnor, MD, FCAP* Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont Mary Beth Beasley, MD, FCAP Department of Pathology, Mt. Sinai Medical Center, New York, New York Philip T. Cagle, MD, FCAP Department of Pathology, The Methodist Hospital, Houston, Texas Steven M. Grunberg, MD Department of Hematology/Oncology, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont Kirk Jones, MD, FCAP Department of Pathology, University of California at San Francisco, San Francisco, California Feng-Ming Kong, MD, PhD, MPH Veteran Administration Health Center/University of Michigan, Ann Arbor, Michigan Alberto Marchevsky, MD, FCAP Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California Nader T. Okby, MD, FCAP Orange Pathology Associates, Orange Regional Medical Center, Middletown, New York Victor L. Roggli, MD, FCAP Department of Pathology, Duke University Medical Center, Durham, North Carolina Saul Suster, MD, FCAP Department of Pathology, The Medical College of Wisconsin, Milwaukee, Wisconsin Henry D. Tazelaar, MD Department of Laboratory Medicine and Pathology, Mayo Clinic Scottsdale, Scottsdale, Arizona William D. Travis, MD, FCAP Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York